Assignee
IMPEL NEUROPHARMA INC
US·10 granted patents·4 pending applications·46 citations·filing 2013–2021
Top patents by PatentIndex Score
14 records- 0189US9550036B2Nasal drug delivery deviceIMPEL NEUROPHARMA INC·Filed 2013·Granted Jan 24, 2017·25 cites·61 claims
- 0288US11185497B2Intranasal delivery of dihydroergotamine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2020·Granted Nov 30, 2021·2 cites·5 claims
- 0385US11191910B2Medical unit dose containerIMPEL NEUROPHARMA INC·Filed 2019·Granted Dec 7, 2021·5 cites·20 claims
- 0483US10507295B2Nasal drug delivery deviceIMPEL NEUROPHARMA INC·Filed 2016·Granted Dec 17, 2019·4 cites·27 claims
- 0581US11007332B2Nozzles for nasal drug deliveryIMPEL NEUROPHARMA INC·Filed 2017·Granted May 18, 2021·2 cites·12 claims
- 0680US11278492B2Intranasal delivery of olanzapine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2019·Granted Mar 22, 2022·1 cites·24 claims
- 0775US11266799B2In-line nasal delivery deviceIMPEL NEUROPHARMA INC·Filed 2016·Granted Mar 8, 2022·2 cites·12 claims
- 0869US9919117B2Nozzles for nasal drug deliveryIMPEL NEUROPHARMA INC·Filed 2013·Granted Mar 20, 2018·3 cites·14 claims
- 0968US2022105030A1Intranasal delivery of dihydroergotamine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2021·Application pending·0 cites
- 1062US10537692B2Medical unit dose containerIMPEL NEUROPHARMA INC·Filed 2014·Granted Jan 21, 2020·2 cites·20 claims
- 1160US10940278B2Nozzles for nasal drug deliveryIMPEL NEUROPHARMA INC·Filed 2018·Granted Mar 9, 2021·0 cites·17 claims
- 1258US2021236485A1Repeated administration of dihydroergotamine for treatment of frequent migraine headachesIMPEL NEUROPHARMA INC·Filed 2021·Application pending·0 cites
- 1356US2019209463A1Intranasal delivery of dihydroergotamine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2019·Application pending·0 cites
- 1444US2015100042A1Muroid Family Nasal DeviceIMPEL NEUROPHARMA INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMPEL NEUROPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →